Zentalis Pharmaceuticals, Inc.ZNTLNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank81
3Y CAGR-0.8%
5Y CAGR+27.3%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
-0.8%/yr
vs +0.1%/yr prior
5Y CAGR
+27.3%/yr
Recent deceleration
Acceleration
-0.9pp
Decelerating
Percentile
P81
Within normal range
vs 5Y Ago
3.3x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 22.31% |
| Q2 2025 | -6.35% |
| Q1 2025 | 17.80% |
| Q4 2024 | 9.86% |
| Q3 2024 | -25.35% |
| Q2 2024 | 32.39% |
| Q1 2024 | -28.02% |
| Q4 2023 | -5.00% |
| Q3 2023 | 51.23% |
| Q2 2023 | -60.86% |
| Q1 2023 | -32.02% |
| Q4 2022 | -12.44% |
| Q3 2022 | 22.84% |
| Q2 2022 | 14.28% |
| Q1 2022 | -35.59% |
| Q4 2021 | -10.54% |
| Q3 2021 | 27.37% |
| Q2 2021 | -23.07% |
| Q1 2021 | -36.96% |
| Q4 2020 | -33.03% |
| Q3 2020 | 6.67% |
| Q2 2020 | -30.60% |
| Q1 2020 | -27.90% |
| Q4 2019 | -32.07% |
| Q3 2019 | -43.55% |
| Q2 2019 | 22.74% |
| Q1 2019 | 0.00% |